Does PEXIDARTINIB Cause Therapy cessation? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Therapy cessation have been filed in association with PEXIDARTINIB (Turalio). This represents 9.7% of all adverse event reports for PEXIDARTINIB.
94
Reports of Therapy cessation with PEXIDARTINIB
9.7%
of all PEXIDARTINIB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Therapy cessation From PEXIDARTINIB?
Of the 94 reports, 2 (2.1%) resulted in death, 6 (6.4%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEXIDARTINIB. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does PEXIDARTINIB Cause?
Fatigue (378)
Product dose omission issue (335)
Hair colour changes (327)
Nausea (213)
Pruritus (186)
Aspartate aminotransferase increased (134)
Rash (131)
Off label use (130)
Alanine aminotransferase increased (124)
Diarrhoea (106)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which PEXIDARTINIB Alternatives Have Lower Therapy cessation Risk?
PEXIDARTINIB vs PHENACETIN
PEXIDARTINIB vs PHENAZOPYRIDINE
PEXIDARTINIB vs PHENCYCLIDINE
PEXIDARTINIB vs PHENELZINE
PEXIDARTINIB vs PHENOBARBITAL